There were exceptional milestones in 2024, where unparalleled knowledge and unwavering dedication radiated from those dedicated to the advancement of cancer research. We made discoveries and shaped the future of oncology through the remarkable contributions of our people.
The K12 Calabresi Clinical Oncology Research Career Development Program continued to nurture the next generation of leaders, including bone marrow transplant researcher Noa Holtzman, M.D., and pancreatic cancer researcher Gretel Terrero, M.D., who joined as new scholars. Their research reflects our mission to translate clinical research into better patient care.
In addition to groundbreaking research and innovation in clinical practice, our commitment to fostering leadership within the cancer care community shined through the new Emerging Leaders Program, led by Sylvester researcher Sophia George, Ph.D., and our partnership with the Miami Herbert Business School. Launched to empower junior and mid-career faculty, the program's first cohort of 12 participants is receiving mentoring that enables them to drive our innovation and lead change in cancer care.
Our researchers embodied the brilliance that defines us, shaping a future where innovation, leadership and compassion converge to redefine cancer care.